Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping
Clinical trial NCT00558311 · COMPLETED
Trial details
- NCT number
- NCT00558311
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-14
- Primary completion
- 2010-06-15
- Enrollment
- 1157
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.